ArticleDermatology and therapy2023

Five-year Maintenance of Clinical Response and Consistent Safety Profile for Guselkumab in Asian patients with Psoriasis from VOYAGE 1 and VOYAGE 2.

Byung Soo Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.